While Dianthus Therapeutics Inc has overperformed by 0.23%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, DNTH rose by 7.01%, with highs and lows ranging from $46.59 to $13.36, whereas the simple moving average jumped by 54.50% in the last 200 days.
On October 14, 2025, Truist started tracking Dianthus Therapeutics Inc (NASDAQ: DNTH) recommending Buy. A report published by William Blair on July 02, 2025, Initiated its previous ‘Outperform’ rating for DNTH. Oppenheimer Initiated an Outperform rating on October 03, 2024, and assigned a price target of $48. Robert W. Baird initiated its ‘Outperform’ rating for DNTH, as published in its report on July 26, 2024. H.C. Wainwright also rated the stock as ‘Buy’.
Analysis of Dianthus Therapeutics Inc (DNTH)
Further, the quarter-over-quarter decrease in sales is -81.77%, showing a negative trend in the upcoming months.
Dianthus Therapeutics Inc’s future performance can be determined with the help of several well-rounded types of analysis and research techniques, with equity being one of the most influential. The goal here is to ensure that your current return on equity of -28.57% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 17.35, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
The average volume for any stock is also a very valuable indicator of volatility, and DNTH has an average volume of 689.84K. On a monthly basis, the volatility of the stock is set at 5.98%, whereas on a weekly basis, it is put at 9.57%, with a gain of 15.48% over the past seven days. Furthermore, long-term investors anticipate a median target price of $68.00, showing growth from the present price of $44.1, which can serve as yet another indication of whether DNTH is worth investing in or should be passed over.
How Do You Analyze Dianthus Therapeutics Inc Shares?
In addition to analyzing the fundamentals, it is also important to look at how many company employees own stock. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 20.03%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 92.73% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
